您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

中国医药研发对照标品提供商
Non-clinical Research-used
Medicine Sample Provider

当前本网站药物产品种数共 8473 处方药 8099 非处方药 268 保健品/医疗用具 106

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:


QQ客服1:1793093587
QQ客服2:1586083059
QQ客服3:2786706041
QQ客服6:2992753224
QQ客服7:2394834588

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 英国药房
产地国家: 英国
所属类别: 作用于消化系统药物->治疗胃食管反流药物
处方药:非处方药
包装规格: 12片/批
计价单位:
  点击放大  
生产厂家中文参考译名:
利洁时
生产厂家英文名:
Reckitt Benckiser
该药品相关信息网址1:
http://www.gaviscon.co.uk/products/gaviscon-double-action/gaviscon-double-action-tablets/gaviscon-double-action-tablets/
原产地英文商品名:
Gaviscon Double Action Tablets 12 tablets/Pack
原产地英文药品名:
sodium alginate, calcium carbonate, sodium bicarbonate
中文参考商品译名:
Gaviscon双动片 12片/批
中文参考药品译名:
海藻酸钠, 碳酸钙, 碳酸氢钠
原产地国家批准上市年份:
0000/00/00
英文适应病症1:
gastroesophageal reflux
临床试验期:
完成
中文适应病症参考翻译1:
胃食管反流症状
药品信息:

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(201882123403825.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文Gaviscon处方资料(仅供参考)


---------------------------------------------------------------

GAVISCON DOUBLE ACTION TABS

定性和定量构成

每个Gaviscon薄荷片含有海藻酸钠250毫克,碳酸氢钠133.5毫克和碳酸钙80毫克。

药物表格

咀嚼片。 一种灰白色至乳白色,略带斑驳的片剂。

临床细节

治疗适应症

治疗胃食管反流症状,如酸反流,胃灼热,消化不良(与反流有关),例如,饭后或怀孕期间或有反流性食管炎相关症状的患者。

行政与行政方法

口腔使用后,彻底咀嚼。 12岁及以上的成人和儿童: 饭后和睡前服用2至4片。

高龄:

此年龄组无需改变剂量。

禁忌

对于已知或怀疑对活性物质或任何赋形剂过敏的患者禁用该药品。

特殊警告和使用注意事项

四片剂量的钠含量为246mg(10.6mmol)。当建议采用高度限制的盐饮食时,应考虑到这一点,例如,在一些充血性心力衰竭和肾功能损害的病例中。 每个四片剂量含有320mg(3.2mmol)碳酸钙。在治疗高钙血症,肾钙质沉着症和复发性钙肾结石患者时需要注意。 由于其阿斯巴甜含量,该药用产品不应给予苯丙酮尿症患者。胃酸水平极低的患者可能会降低疗效。

Gaviscon  

 
Generic name: 
talimogene laherparepvec

Company: Amgen Inc. 

QUALITATIVE & QUANTITATIVE COMPOSITION

Each Gaviscon Peppermint Tablet contains sodi- um alginate 250mg, sodium hydrogen carbonate 133.5 mg and calcium carbonate 80 mg.

PHARMACEUTICAL FORM

Chewable Tablet. An off-white to cream, slightly mottled tablet.

CLINICAL PARTICULARS

Therapeutic Indications

Treatment of symptoms of gastro-oesophageal reflux such as acid regurgitation, heartburn, indiges- tion (related to reflux), for example, following meals or during pregnancy or in patients with symptoms related to reflux oesophagitis.

Posology & Method of Administration

For oral use, after being thoroughly chewed. Adults and children 12 years and over: Two to four tablets after meals and at bedtime.

Elderly:

No dose modifications necessary for this age group.

Contraindications

This medicinal product is contraindicated in patients with known or suspected hypersensitivity to the active substances or to any of the excipients.

Special warnings and precautions for use

The sodium content of a four-tablet dose is 246mg (10.6 mmol). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment. Each four-tablet dose contains 320 mg (3.2 mmol) of calcium carbonate. Care needs to be taken in treat- ing patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi. Due to its aspartame content this medicinal product should not be given to patients with phenylketonuria. There is a possibility of reduced efficacy in patients with very low levels of gastric acid.

---------------------------------------------------------------

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(201882123403825.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------

更新日期: 2018-07-30
附件:
201882123403825.pdf    

 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:info.shijiebiaopin.com@gmail.com, info@shijiebiaopin.com